FindTrial
Sign In

To determine the association of Substance P marker level in blood and CSF in chronic pain patients

Correlation of Substance P level in Blood and CSF in patients of Chronic Pain Syndromes : A Cross Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041834
Enrollment
16
Registered
2022-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G894- Chronic pain syndrome

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

All india institute of medical sciences Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with chronic pain syndromes, Pain at least 6 months duration

Exclusion criteria

Exclusion criteria: Patients with a history of alcohol or drug abuse or with psycho-organic cerebral syndromes is excluded. None of the patients had previously been taking narcotic analgesics. Pain is not due to somatization disorder or major depression

Design outcomes

Primary

MeasureTime frame
To measure Substance P level in blood in patients of chronic pain syndrome To measure Substance P level in CSF in patients of chronic pain syndrome To correlate the VAS score with the substance P level in serum and CSF level in patients of chronic pain syndrome. Timepoint: after 6 months of symptom onset single reading—

Secondary

MeasureTime frame
Assessment of demographic variation Variation in VAS of different types chronic pain syndromes Timepoint: Baseline, 4 weeks—

Countries

India

Contacts

Public ContactAjit Kumar

Anesthesia department, AIIMS Rishikesh

ajitdr.ajit@gmail.com9910789377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026